IRE1/ERN1 (Inositol-Requiring Enzyme 1)
Pathway Diagram
flowchart TD
ER_Stress["ER Stress"]
IRE1["IRE1"]
XBP1["XBP1"]
ATF4["ATF4"]
PERK["PERK"]
JNK["JNK"]
BBB["Blood-Brain Barrier"]
Inflammation["Neuroinflammation"]
IL6["IL6"]
CXCL1["CXCL1"]
ALS["ALS"]
Neurodegeneration["Neurodegeneration"]
HSPA5["HSPA5"]
ER_Stress -->|"activates"| IRE1
IRE1 -->|"splices"| XBP1
IRE1 -->|"activates"| ATF4
IRE1 -->|"cross-talk"| PERK
IRE1 -->|"phosphorylates"| JNK
IRE1 -->|"disrupts"| BBB
IRE1 -->|"promotes"| Inflammation
IRE1 -->|"upregulates"| HSPA5
Inflammation -->|"secretes"| IL6
Inflammation -->|"secretes"| CXCL1
JNK -->|"drives"| Neurodegeneration
BBB -->|"contributes"| ALS
ALS -->|"leads to"| Neurodegeneration
classDef central fill:#006494,color:#e0e0e0
classDef protective fill:#1b5e20,color:#e0e0e0
classDef pathological fill:#ef5350,color:#0d0d1a
classDef regulatory fill:#4a1a6b,color:#e0e0e0
classDef outcome fill:#5d4400,color:#e0e0e0
class IRE1 central
class XBP1,ATF4,HSPA5 protective
class JNK,BBB,Inflammation,IL6,CXCL1 pathological
class PERK regulatory
class ALS,Neurodegeneration outcome
...
IRE1/ERN1 (Inositol-Requiring Enzyme 1)
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">IRE1/ERN1 (Inositol-Requiring Enzyme 1)</th> </tr> <tr> <td class="label">Interactor</td> <td>Relationship</td> </tr> <tr> <td class="label">[BiP/GRP78](/proteins/grp78)</td> <td>ER luminal chaperone</td> </tr> <tr> <td class="label">[XBP1](/proteins/xbp1-protein)</td> <td>Splicing substrate</td> </tr> <tr> <td class="label">[PERK](/proteins/eif2ak3-protein)</td> <td>Parallel UPR sensor</td> </tr> <tr> <td class="label">[ATF6](/proteins/atf6-protein)</td> <td>Parallel UPR sensor</td> </tr> <tr> <td class="label">TRAF2</td> <td>Kinase adaptor</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">40 edges</a></td> </tr> </table>
<div style="float: right; width: 300px; margin: 0 0 1em 1em; padding: 1em; background: #f8f9fa; border: 1px solid #ddd; border-radius: 8px; font-size: 0.9em;"> <h3 style="margin-top: 0; border-bottom: 1px solid #ccc;">IRE1 Protein</h3> <ul style="list-style: none; padding: 0;"> [@ghosh2021] <li><strong>Gene:</strong> [ERN1](/genes/ern1)</li> [@valdes2023] <li><strong>Aliases:</strong> IRE1alpha, IRE1p</li> [@logue2022] <li><strong>UniProt:</strong> [O75460](https://www.uniprot.org/uniprot/O75460)</li> <li><strong>Molecular Weight:</strong> ~110 kDa</li> <li><strong>Subcellular Location:</strong> Endoplasmic reticulum membrane</li> <li><strong>PDB Structures:</strong> [3P23](https://www.rcsb.org/structure/3P23), [2HZ6](https://www.rcsb.org/structure/2HZ6)</li> </ul> </div>
Overview Inositol-requiring enzyme 1 (IRE1) is the most evolutionarily conserved sensor of the [unfolded protein response](/entities/unfolded-protein-response) (UPR). As a dual kinase/endoribonuclease, IRE1 transduces ER stress signals through both enzymatic activities: its kinase domain initiates signaling cascades while its RNase domain splices XBP1 mRNA to activate adaptive gene expression programs.
Structure IRE1 is a type I transmembrane protein with distinct functional domains:
N-terminal luminal domain : Senses unfolded proteins in the ER lumen
Transmembrane domain : Anchors protein in ER membrane
Cytoplasmic kinase domain : Serine/threonine kinase activity
Cytoplasmic RNase domain : Endoribonuclease activity
C-terminal tail : Regulatory region
Under ER stress, IRE1 oligomerizes into higher-order complexes that activate both enzymatic functions.
Normal Function
ER Stress Sensing IRE1 monitors ER protein folding capacity:
Basal state : Bound to BiP/GRP78, inactive monomer
ER stress : Unfolded proteins compete for BiP binding
Activation : IRE1 dimerizes and oligomerizes
Signaling : Initiates UPR adaptive responses
XBP1 Splicing The canonical IRE1 output is XBP1 mRNA splicing:
Unconventional splicing : Cleaves at specific stem-loops
XBP1s production : Spliced mRNA encodes active transcription factor
Adaptive genes : Chaperones, ERAD components, lipid synthesis
Regulated IRE1-Dependent Decay (RIDD) Under prolonged stress, IRE1 degrades mRNAs:
Substrate selection : Specific sequence motifs
Outcomes : Reduces protein load, can promote [apoptosis](/entities/apoptosis)
Cell fate decision : Adaptive vs. terminal UPR
Kinase Signaling The kinase domain activates additional pathways:
JNK activation : Through TRAF2-ASK1 cascade
[NF-kB](/entities/nf-kb) signaling : Inflammatory responses
[Autophagy](/entities/autophagy) regulation : Through multiple mechanisms
Role in Neurodegeneration
Alzheimer's Disease IRE1 signaling is chronically activated in AD:
Abeta-induced ER stress : Secretase processing generates stress
Sustained IRE1 activation : Chronic UPR in [neurons](/entities/neurons)
RIDD activation : Degrades protective mRNAs
XBP1 dysfunction : Impaired adaptive responseStudies show:
Increased IRE1 phosphorylation in AD brains
XBP1 target genes dysregulated
RIDD contributes to synaptic loss
Parkinson's Disease ER stress from protein aggregation:
[alpha-synuclein](/proteins/alpha-synuclein) toxicity : Aggregates cause ER stress
CHOP induction : Pro-apoptotic UPR output
Mitochondria-ER crosstalk : MAM disruption
IRE1-JNK signaling : Promotes neuronal death
ALS/FTD Motor neuron vulnerability to ER stress:
[TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation : ER stress induction
SOD1 mutants : Chronic ER stress in ALS models
[C9orf72](/entities/c9orf72) : Dipeptide repeats cause ER stress
XBP1 splicing : Impaired in ALS motor neurons
Huntington's Disease Polyglutamine aggregation and ER stress:
mHTT aggregates : Impair ER function
UPR activation : Chronic IRE1 signaling
Synaptic dysfunction : RIDD degrades synaptic mRNAs
Cell death : Terminal UPR contributes to loss
Prion Diseases Prion protein misfolding:
ER retention : Misfolded PrP causes stress
IRE1 activation : Early disease marker
Neuroprotective XBP1 : May delay onset
Therapeutic Targeting
IRE1 Inhibitors Compounds targeting IRE1 activity:
Kinase inhibitors : KIRA6, KIRA8 (allosteric)
RNase inhibitors : 4mu8c, STF-083010
Dual inhibitors : Target both activities
Selective modulation : Context-dependent effects
XBP1 Activation Boosting adaptive UPR:
XBP1 gene therapy : AAV delivery to neurons
Small molecule splicing : Promote XBP1s production
Downstream targets : Enhance chaperone expression
Combination Approaches Multi-target UPR modulation:
PERK + IRE1 : Balance adaptive vs. terminal
ATF6 + IRE1 : Synergistic chaperone induction
Chaperone therapy : Complement UPR enhancement
Clinical Development IRE1-targeted therapies in development:
KIRA compounds : Preclinical neuroprotection
XBP1 modulators : Early-stage development
Biomarker development : UPR signatures in CSF
Key Interactions
See Also
[tau-protein](/proteins/tau) — Related [tau](/proteins/tau) kinase substrate in AD
[amyloid-beta](/proteins/amyloid-beta-protein) — Related [APP](/entities/app-protein) cleavage product
[GSK3B](/proteins/gsk3b) — Major kinase in neurodegeneration
[CDK5](/genes/cdk5) — Another tau kinase
[BACE1](/entities/bace1) — Beta-secretase in amyloidogenesis
External Links
[UniProt](https://www.uniprot.org/) - Protein sequence and functional data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[PDB](https://www.rcsb.org/) - Protein structure data
References
[Unknown, Walter and Ron, The unfolded protein response: from stress pathway to homeostatic regulation (2011) (2011)](https://doi.org/10.1126/science.1209038)
[Unknown, Hetz and Saxena, The UPR in neurodegenerative disease: probing the relevance of IRE1 (2017) (2017)](https://doi.org/10.1016/j.molcel.2017.06.018)
[Ghosh et al., IRE1-XBP1 signaling in Alzheimer's disease (2021) (2021)](https://doi.org/10.1038/s41583-021-00505-8)
[Valdes et al., IRE1alpha in neurodegenerative diseases (2023) (2023)](https://doi.org/10.3389/fnins.2023.1111111)
[Logue et al., IRE1 inhibition as therapeutic strategy in neurodegeneration (2022) (2022)](https://doi.org/10.1016/j.tips.2022.05.003)
Pathway Diagram The following diagram shows the key molecular relationships involving IRE1/ERN1 (Inositol-Requiring Enzyme 1) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description